Abstract
RETROSPECTIVE ANALYSIS OF FOLFOX VERSUS FOLFOX AND CETUXIMAB FOR PATIENTS WITH METASTATIC CANCER COLON

Eman El-sheikh, Amr Lotfy, Nesreen Ahmed Mosalam and Kyrillous Mounir Beniamin*

ABSTRACT

Background: Cetuximab which is a monoclonal antibody can be added to folfox regimen in treatment of patients with RAS wild metastatic cancer colon and this may improve the progression free survival and overall survival of these patients. We investigated the efficacy of cetuximab plus oxaliplatin, fluorouracil, and leucovorin (FOLFOX) as first-line treatment for metastatic colorectal cancer. Objective: To retrospective analyses of progression-free survival, overall survival, overall response rate, resectability and safety within the different patient populations with metastatic cancer colon treated by cetuximab plus FOLFOX versus FOLFOX alone. Patients and Methods: A Retrospective controlled trial study, 100 patients were selected to participate in our study based on our inclusion criteria. They were recruited from Ain shams University Teaching Hospital and Alexandria Military Hospital, from January 2012 to December 2016. Results: The initial treatment of metastatic colorectal cancer with a combination of Cetuximab plus FOLFOX, as compared with FOLFOX alone, reduced the risk of disease progression by 33.4% and also increased the response rate by nearly 13%. There was significant difference between the treatment groups in overall survival by 39%. Conclusion: First-line treatment with cetuximab plus FOLFOX, as compared with FOLFOX alone, reduced the risk of progression of metastatic colorectal cancer.

Keywords: Epidermal growth factor receptor, intention-to-treat.


[Full Text Article]

Login





Forgot Password  |  Register

Indexing

Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.

Best Article of current issue :

Tangudu Nagabhusana Rao

Download Article : Click here

News & Updation

  • EJBPS: JANUARY ISSUE PUBLISHED

    JANUARY 2020 Issue has been successfully launched on 1 January 2020.

  • EJBPS New Impact Factor

    Its our Pleasure to Inform you that EJBPS Impact Factor has been increased from 5.467 to 6.044, due to high quality Publication at International Level.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.

     

UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS

Downloads

Copyright From

Covering Letter

                        Author Instruction 
 

PLAGERLUM REPORT